RVNC

Revance Therapeutics Inc

Price:

2.80

USD

Volume:

1,458,811.00

United States | Pharmaceuticals

-642.56 %

Upside

As of 2024-06-18, the Fair Value of Revance Therapeutics Inc (RVNC) is -15.19 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 2.80 USD, the upside of Revance Therapeutics Inc is -642.56%.

Note: valuation result may not be accurate due to the company's negative EPS.

2.80 USD

Stock Price

-15.19 USD

Fair Price

Peter Lynch's formula is:

RVNC Fair Value

= Earnings Growth Rate x TTM EPS
RVNC Fair Value

= 5.00 x -3.04
RVNC Fair Value

= -15.19
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.

Historical Earnings | ||||||

2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |

Net income | -159.40 | -282.10 | -281.30 | -356.40 | -323.99 | -280.64 |

YoY growth | -11.78% | -76.98% | 0.28% | -26.70% | 9.09% | -21.22% |

Market Cap (mil) | 292.46 |

P/E | |

Forward P/E |

EPS | -3.04 |

Avg earnings growth rate | -21.22% |

TTM earnings | -317.35 |